Health-Related Quality of Life in the Era of Immune Checkpoint Blockade: What Do Patient-Reported Outcomes Reveal?

Cancers (Basel) · 2025 · PMC12730945 · PMID 41463169

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Common Themes in HRQL with Immunotherapy Use Across the different classes of ICIs, a clear trend emerges: patients’ HRQL is better preserved while on immunotherapy than the traditional cytotoxic therapies.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.